Aug 14, 2026 07:54AM
Aug 14, 2026 06:38AM
Aug 12, 2026 07:59AM
Aug 12, 2026 07:23AM
Jul 22, 2026 06:51AM
Jun 16, 2026 06:44AM
Jun 15, 2026 03:02AM Belite Bio completes FDA drug application for rare eye disease treatment
May 26, 2026 05:50AM
May 22, 2026 09:33AM
May 21, 2026 06:38AM
May 20, 2026 06:03AM
May 18, 2026 04:00PM
Apr 21, 2026 04:00PM
Apr 13, 2026 06:38AM H.C. Wainwright Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)
Apr 13, 2026 05:52AM
Apr 7, 2026 07:46AM
Mar 4, 2026 08:42AM
Mar 4, 2026 06:42AM
Mar 3, 2026 09:37AM
Mar 3, 2026 07:44AM
Mar 2, 2026 04:27PM Belite Bio (BLTE) Tops Q4 EPS by 15c
Jan 28, 2026 06:43AM
Jan 27, 2026 08:04AM
Jan 26, 2026 06:12AM
Jan 16, 2026 07:08AM
Jan 6, 2026 02:10AM
Dec 3, 2025 08:44AM
Dec 2, 2025 05:06AM Mizuho Upgrades Belite Bio, Inc, ADR (BLTE) to Outperform
Nov 24, 2025 06:12AM
Nov 20, 2025 05:36AM
Nov 11, 2025 03:51PM
Nov 10, 2025 05:11PM
Nov 3, 2025 03:52AM
Oct 17, 2025 06:46AM
Oct 15, 2025 08:02AM Belite Bio receives China NMPA priority review for Stargardt treatment
Sep 15, 2025 07:28AM
Sep 10, 2025 08:51AM
Aug 12, 2025 09:42AM
Aug 11, 2025 06:32AM
Jul 3, 2025 06:46AM
May 22, 2025 08:39AM
May 15, 2025 09:10AM Benchmark Reiterates Buy Rating on Belite Bio, Inc, ADR (BLTE)
May 15, 2025 07:23AM
May 14, 2025 04:52PM
Mar 26, 2025 08:39AM
Mar 18, 2025 06:41AM
Mar 17, 2025 07:06AM
Mar 17, 2025 06:06AM
Jan 21, 2025 06:49AM Belite Bio, Inc, ADR (BLTE) PT Raised to $79 at Benchmark
Nov 13, 2024 06:52AM

456,295 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All